We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Vor Biopharma Inc | NASDAQ:VOR | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.0133 | 1.50% | 0.90 | 0.85 | 0.92 | 0.8817 | 0.8443 | 0.87 | 232,734 | 05:00:08 |
From Jun 2024 to Dec 2024
Morgan Stanley 22nd Annual Global Healthcare Conference1x1 Investor Meetings: Friday, September 6, 2024Location: New York, NY
Baird 2024 Global Healthcare Conference Fireside Chat: Wednesday, September 11, 2024, at 7:55am ETLocation: New York, NY
Chardan’s 8th Annual Genetic Medicines Conference Fireside Chat: Monday, September 30, 2024, at 4:30pm ETLocation: New York, NY
About Vor BioVor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant. For more information, visit: www.vorbio.com.
Contact:
Media & InvestorsSarah Spencer +1 857-242-6076sspencer@vorbio.com
1 Year Vor Biopharma Chart |
1 Month Vor Biopharma Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
